[急性髓性白血病的分子向治疗]
1Department of Hematology and Oncology, Nagoya University Graduate School of Medicine.
概括
新型疗法正在改善急性髓性白血病 (AML) 的治疗结果. 最近的进展包括向药物和免疫疗法,为患有这种复杂的血液癌症的患者提供了新的希望.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 急性髓性白血病 (AML) 是一种复杂的血液癌症,其特点是多种遗传异常.
- 近年来,在AML分类和向治疗方面取得了重大进展.
研究的目的:
- 审查AML治疗策略的不断变化的格局.
- 突出新型分子向疗法和组合疗法的影响.
主要方法:
- 审查最近的临床试验和AML治疗指南更新.
- 分析已批准和正在研究的疗法,包括小分子抑制剂和免疫疗法.
主要成果:
- 与中素和化疗的联合治疗改善了FLT3-ITD阳性AML的结果.
- 一些针对CD47,TIM-3和其他途径的新型药物正在临床研究中.
结论:
- 结合新型治疗方式与化疗相结合,有望改善AML患者的预后.
- 进一步研究耐火性AML的病原性对于优化未来的治疗策略至关重要.
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:50Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K